Lib Therapeutics Submits a Biologic License Application to FDA for Lerodalcibep for the Treatment of Adults With Elevated Ldl-Cholesterol
Lib Therapeutics向FDA提交了一份生物许可证申请,申请用于治疗高胆固醇成人的Lerodalcibep。
Lib Therapeutics Submits a Biologic License Application to FDA for Lerodalcibep for the Treatment of Adults With Elevated Ldl-Cholesterol
Lib Therapeutics向FDA提交了一份生物许可证申请,申请用于治疗高胆固醇成人的Lerodalcibep。
使用浏览器的分享功能,分享给你的好友吧